AbstractMale infertility is a multifactorial condition encompassing a wide range of disorders. Approximately one in eight couples experience difficulty conceiving their first child, and one in six faces challenges conceiving a subsequent child. This study was designed to evaluate various seminal parameters and investigate the role of the GSK3A gene before and after in vitro sperm activation with FertiCult™ Flushing Medium, in order to explore its contribution to the etiology and pathogenesis of infertility among the samples of Iraqi men.
Semen samples were collected from 125 men attending Al-Najaf Fertility Center at Al-Sader Medical City (Ministry of Health, Najaf, Iraq) during the period from September 2024 to September 2025. According to the World Health Organization (WHO ( 2021 guidelines, samples were categorized into four groups based on sperm concentration, progressive motility, and morphology: Group 1 included 25 asthenozoospermic men. Group 2 included 25 oligoozoospermic men. Group 3 included 25 oligoasthenozoospermic men and Group 4 fifty healthy, fertile men were included as normozoospermic men.
Detection of anti-sperm antibodies (ASAs) was performed before in vitro activation using the SpermMar test, to assess possible immunological factors influencing sperm function or fertilization capacity. In parallel, the activity of Glycogen Synthase Kinase-3 (GSK3) and the level of the pro-inflammatory cytokine, Interleukin-6 (IL-6) in seminal plasma were measured before activation, as indicators of sperm regulatory and inflammatory status, respectively. Both parameters were quantified using the Enzyme-Linked Immunosorbent Assay (ELISA) technique. At the molecular level, quantitative expression of the GSK3A gene was analyzed by real-time PCR. While the genetic aspect, the Single Nucleotide Polymorphisms (SNPs) within the gene were identified through sequencing using specific primers and conventional PCR. A strong association was also observed between ASA positivity and abnormal semen characteristics. Regarding biochemical markers, GSK3α levels were significantly elevated in the semen of asthenozoospermic group compared to the control and other patient subgroups, on the other hand IL-6 concentrations were significantly higher across all infertile subgroups than in the fertile control group. The results revealed highly significant differences (p< 0.05) in sperm concentration, motility, and morphology between fertile and infertile men post- activation compared to prior- activation.
Quantitative analysis of GSK3A gene expression in semen samples revealed distinct patterns before and after in vitro sperm activation. Before activation, mRNA levels of GSK3A were significantly (p< 0.05) upregulated in infertile subgroups compared to the fertile control group, indicating a potential compensatory or dysregulated role of this gene in impaired sperm function. Following in vitro activation, GSK3A expression was downregulated across all patient subgroups relative to controls, with fold changes below 1.0, suggesting that activation modulates gene expression and potentially restores or alters regulatory pathways associated with sperm motility and function. Consequently, Sequencing analysis of the GSK3A gene revealed two single-nucleotide polymorphisms located within exon 7 at positions 42,233,325 and 42,233,340 on chromosome 19. Both variants were confirmed through BLAST alignment with the GenBank reference sequence and were identified as rs2513500538 and a T>A substitution, respectively. In conclusion, these findings highlight a dynamic regulation of GSK3A in response to sperm activation, supporting its role in sperm physiology and providing a molecular basis for its involvement in idiopathic and unexplained male infertility.